Hong Kong Stocks Rise as ETF Listings Boost Sentiment; Biolabs Falls 4%

MT Newswires Live

Sep 28

Hong Kong stocks rose Monday as eight new ETFs began trading in the city, with asset managers looking to tap mainland insurance funds through the expanded Southbound Stock Connect.

The Hang Seng Index rose 132.42 points, or 0.5%, to close at 24,642.51, while the Hang Seng China Enterprises Index gained 51.06 points, or 0.6%, to 8,216.84.

Meanwhile, the Hang Seng TECH 100 Index fell 1.3% as mainland markets came under pressure from new U.S. restrictions on Chinese-made components used in AI data centers.

In company news, Nanjing Leads Biolabs' (HKG:9887) cancer treatment LBL-024 received orphan drug designation in Japan, adding to similar designations in the U.S. and Europe. Shares of the company fell more than 4%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/2670280014"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2670280014\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2670280014?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-28 16:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2670280014","market":"nz","top_or_hot":-1,"title":"Hong Kong Stocks Rise as ETF Listings Boost Sentiment; Biolabs Falls 4%","media":"MT Newswires Live","content":"<html><body><p> Hong Kong stocks rose Monday as eight new ETFs began trading in the city, with asset managers looking to tap mainland insurance funds through the expanded Southbound Stock Connect.</p><p>The <a href=\"https://laohu8.com/S/HSNGY\">Hang Seng</a> Index rose 132.42 points, or 0.5%, to close at 24,642.51, while the Hang Seng <a href=\"https://laohu8.com/S/CSHEF\">China Enterprises</a> Index gained 51.06 points, or 0.6%, to 8,216.84.</p><p>Meanwhile, the Hang Seng TECH 100 Index fell 1.3% as mainland markets came under pressure from new U.S. restrictions on Chinese-made components used in AI data centers.</p><p>In company news, Nanjing Leads Biolabs' (HKG:9887) cancer treatment LBL-024 received orphan drug designation in Japan, adding to similar designations in the U.S. and Europe. Shares of the company fell more than 4%.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stocks Rise as ETF Listings Boost Sentiment; Biolabs Falls 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stocks Rise as ETF Listings Boost Sentiment; Biolabs Falls 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-28 16:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Hong Kong stocks rose Monday as eight new ETFs began trading in the city, with asset managers looking to tap mainland insurance funds through the expanded Southbound Stock Connect.</p><p>The <a href=\"https://laohu8.com/S/HSNGY\">Hang Seng</a> Index rose 132.42 points, or 0.5%, to close at 24,642.51, while the Hang Seng <a href=\"https://laohu8.com/S/CSHEF\">China Enterprises</a> Index gained 51.06 points, or 0.6%, to 8,216.84.</p><p>Meanwhile, the Hang Seng TECH 100 Index fell 1.3% as mainland markets came under pressure from new U.S. restrictions on Chinese-made components used in AI data centers.</p><p>In company news, Nanjing Leads Biolabs' (HKG:9887) cancer treatment LBL-024 received orphan drug designation in Japan, adding to similar designations in the U.S. and Europe. Shares of the company fell more than 4%.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_MCH","symbol_name":"小H股指","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2670280014","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2670280014","pubTimestamp":1790585483,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hong Kong stocks rose Monday as eight new ETFs began trading in the city, with asset managers looking to tap mainland insurance funds through the expanded Southbound Stock Connect.The Hang Seng Index rose 132.42 points, or 0.5%, to close at 24,642.51, while the Hang Seng China Enterprises Index gained 51.06 points, or 0.6%, to 8,216.84.Meanwhile, the Hang Seng TECH 100 Index fell 1.3% as mainland markets came under pressure from new U.S. restrictions on Chinese-made components used in AI data centers.In company news, Nanjing Leads Biolabs'  cancer treatment LBL-024 received orphan drug designation in Japan, adding to similar designations in the U.S. and Europe. Shares of the company fell more than 4%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"82800":"盈富基金-R","82828":"恒生中国企业-R","83115":"安硕恒生指数—R","513600":"恒生指数ETF南方","07226":"南方两倍做多恒科","02800":"盈富基金","03037":"南方恒指ETF","02837":"GX恒生科技","03416":"AGX国指兑","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元","02802":"A南方国指备兑","HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","09115":"安硕恒生指数—U","HSCEI":"国企指数","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元","02828":"恒生中国企业","03067":"安硕恒生科技","07500":"南方两倍做空恒指","03423":"招商恒生科技","HSI":"恒生指数","BK1161":"生物科技","HSTECH":"恒生科技指数","09887":"维立志博-B","02833":"恒指ETF","07288":"FL二南方国指","03088":"华夏恒生科技","03032":"恒生科技ETF","07552":"南方两倍做空恒科","03115":"安硕恒生指数","07300":"南方一倍看空恒指","03033":"南方恒生科技","03419":"A GX恒指备兑","09088":"华夏恒生科技-U","09067":"安硕恒生科技-U","03417":"AGX恒科备兑","07588":"FI二南方国指","07200":"南方两倍做多恒指"},"translate_title":"ETF上市提振市场情绪，香港股市上涨；Biolabs 下跌 4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"82800":0.6,"82828":0.6,"83115":0.6,"513600":0.6,"HSCEI":1.86,"HSTECH":1.83,"02828":0.6,"02800":0.6,"03423":0.6,"07288":0.6,"03417":0.6,"07500":0.6,"03088":0.6,"09115":0.6,"03037":0.6,"HSI":1.83,"09887":1.9,"07300":0.6,"07588":0.6,"03033":0.6,"02833":0.6,"02837":0.6,"02802":0.6,"HHImain":0.6,"03416":0.6,"07200":0.6,"MHImain":0.6,"MCHmain":0.6,"03067":0.6,"07226":0.6,"03032":0.6,"03419":0.6,"09088":0.6,"03115":0.6,"09067":0.6,"07552":0.6},"content_text":"Hong Kong stocks rose Monday as eight new ETFs began trading in the city, with asset managers looking to tap mainland insurance funds through the expanded Southbound Stock Connect.The Hang Seng Index rose 132.42 points, or 0.5%, to close at 24,642.51, while the Hang Seng China Enterprises Index gained 51.06 points, or 0.6%, to 8,216.84.Meanwhile, the Hang Seng TECH 100 Index fell 1.3% as mainland markets came under pressure from new U.S. restrictions on Chinese-made components used in AI data centers.In company news, Nanjing Leads Biolabs' (HKG:9887) cancer treatment LBL-024 received orphan drug designation in Japan, adding to similar designations in the U.S. and Europe. Shares of the company fell more than 4%.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}